Clicky

STAAR Surgical Company(SR3)

Description: STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.


Keywords: Ophthalmology Vision Corrective Lenses Surgical Specialties Myopia Presbyopia Astigmatism Hyperopia Farsightedness Phakic Intraocular Lens Visual Disorders

Home Page: www.staar.com

25651 Atlantic Ocean Drive
Lake Forest, CA 92630
United States
Phone: 626 303 7902


Officers

Name Title
Mr. Thomas G. Frinzi President, CEO & Chairman
Mr. Patrick F. Williams Chief Financial Officer
Mr. Warren Foust Chief Operating Officer
Dr. Keith Holliday Ph.D. Chief Technology Officer
Dr. Scott D. Barnes M.D. Chief Medical Officer
Mr. Brian Moore Vice President of Investor Relations & Corporate Development
Mr. Nathaniel B. Sisitsky Esq. General Counsel & Corporate Secretary
Ms. Nancy Sabin Chief Marketing Officer
Mr. James Francese Senior Vice President of Commercial Operations - North America & APAC
Dr. Magda Michna Ph.D. Chief Clinical, Regulatory & Medical Affairs Officer

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 196.0784
Trailing PE: 56.881
Price-to-Book MRQ: 2.9106
Price-to-Sales TTM: 3.4673
IPO Date:
Fiscal Year End: December
Full Time Employees: 1056
Back to stocks